MedPath

Sint Franciscus Gasthuis

🇳🇱Netherlands
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.sfg.nl

Clinical Trials

53

Active:1
Completed:31

Trial Phases

4 Phases

Phase 2:1
Phase 3:2
Phase 4:6
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Phase 4
6 (50.0%)
Not Applicable
3 (25.0%)
Phase 3
2 (16.7%)
Phase 2
1 (8.3%)

Regional Activation of Leukocytes in Coronary Artery Disease

Completed
Conditions
Coronary Artery Disease
Inflammation
First Posted Date
2015-03-03
Last Posted Date
2015-03-03
Lead Sponsor
Sint Franciscus Gasthuis
Target Recruit Count
97
Registration Number
NCT02376738
Locations
🇳🇱

Sint Franciscus Gasthuis, Rotterdam, Zuid-Holland, Netherlands

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

Not Applicable
Completed
Conditions
Atherosclerosis
Leukocyte Activation Disorder
Type 2 Diabetes Mellitus
Familial Combined Hyperlipidemia
First Posted Date
2014-05-05
Last Posted Date
2014-05-05
Lead Sponsor
Sint Franciscus Gasthuis
Target Recruit Count
51
Registration Number
NCT02130505

Effects Vitamin D Suppletion on Postprandial Leukocyte Activation

Not Applicable
Completed
Conditions
Atherosclerosis
Oxidative Stress
Leukocyte Activation Disorder
Interventions
First Posted Date
2013-10-23
Last Posted Date
2017-10-05
Lead Sponsor
Sint Franciscus Gasthuis
Target Recruit Count
24
Registration Number
NCT01967459
Locations
🇳🇱

Sint Franciscus Gasthuis, Rotterdam, Zuid-Holland, Netherlands

Diurnal Triglyceridemia in Relation to Alcohol Intake

Completed
Conditions
Healthy Subjects
Hyperlipidemias
Type 2 Diabetes Mellitus
Cardiovascular Diseases
First Posted Date
2013-02-08
Last Posted Date
2013-02-08
Lead Sponsor
Sint Franciscus Gasthuis
Target Recruit Count
273
Registration Number
NCT01786421
Locations
🇳🇱

Sint Franciscus Gasthuis, Rotterdam, Netherlands

🇳🇱

Utrecht University Medical Center, Utrecht, Netherlands

Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy

Not Applicable
Completed
Conditions
Hyperlipidemia
Atherosclerosis
Interventions
Drug: Temporary discontinuation of statin therapy
First Posted Date
2012-07-06
Last Posted Date
2013-03-22
Lead Sponsor
Sint Franciscus Gasthuis
Target Recruit Count
55
Registration Number
NCT01634906
Locations
🇳🇱

Sint Franciscus Gasthuis, Rotterdam, Zuid Holland, Netherlands

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.